Montserrat Hoyos

Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post-remission therapy

Marta Pratcorona, Salut Brunet, Josep Nomdedéu et al. · Blood · 2013 · 279 citations

CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.

Arianne Pérez-García, Rafael de la Cámara, José Román‐Gómez et al. · Blood · 2007 · 81 citations · Full text

Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML

Josep Nomdedéu, Montserrat Hoyos, Maite Carricondo et al. · Leukemia · 2013 · 72 citations

Hematological Malignancy, Medicine, Hematology +5

CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy

A. Perez-Garcia, Salut Brunet, Juan José Berlanga et al. · Leukemia · 2008 · 55 citations

Hematological Malignancy, Relapse Incidence, Ctla-4 Genotype +11

Adverse impact of IDH1 and IDH2 mutations in primary AML: Experience of the Spanish CETLAM group

Josep Nomdedéu, Montserrat Hoyos, Maite Carricondo et al. · Leukemia Research · 2012 · 47 citations

Spanish Cetlam Group, Somatic Variant, Genetic Disorder +10